Catalyst Pharmaceutical Partners
One more stock that's worth keeping on your breakout trading radar is Catalyst Pharmaceutical Partners (CPRX), which is focused on the development and commercialization of prescription drugs targeting addiction and diseases of the central nervous system. This stock has been trending modestly high in 2011, with shares up by around 7%.
If you look at the chart for Catalyst Pharmaceutical Partners, you'll see that this stock spiked big today and broke out above $1.20 to $1.21 a share on monster volume. The reason for the monster spike and volume was due to news that their investigational drug, CPP-115 has been designated as a Fast Track development program by the FDA for treatment of cocaine dependency. Off that news, the stock touched $1.39 a share and volume has already registered over 440,000 shares, which is well above its three-month average volume of 120,445 shares.
Market players should now watch for a sustained move and close back above $1.20 to $1.21 a share to trigger another breakout trade. Since those breakout levels were only tested intraday, I would now like to see if CPRX can close above those levels with volume. If we can get above those levels on the close, then this stock can setup to re-test $1.39, or potentially trend much higher. Keep in mind that traders sold the news, so this stock is going to need to regain its upside momentum to look attractive from the long side.One could be a buyer of this stock near its current level of $1.10 a share and anticipate another big spike higher. I would simply use a mental stop at a major near-term support zone of $1.01 a share in case the bullish move is over. I would add to any long positions in CPRX on a close above its 200-day moving average of $1.31 and then above today's high of $1.39 on high-volume. If we get that action, this stock has upside towards $1.46 to $1.90 a share. To see more breakout candidates, including Salix Pharmaceuticals (SLXP), Westport Innovations (WPRT) and Kratos Defense & Security Solutions (KTOS), check out the Breakout Stocks of the Week portfolio on Stockpickr. -- Written by Roberto Pedone in Winderemere, Fla.
Twitter and become a fan on Facebook.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV